Drawing for Serial No. 97142631

USPTO serial 97142631

Serial No. 97142631

Reviewed by CopyMark Law Group

Reg. 8402999Status 700Registered
Filing date
Status date
Registration date
Aug 18, 2026
Examiner
KUNG, KAELIE ELIZABETH
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with Serial No. 97142631?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael E. Dukes

Michael E. Dukes DENTONS COHEN & GRIGSBY P.C.625 LIBERTY AVENUEPITTSBURGH, PA 15222United States

Goods and services

ClassDescriptionStatusFirst use
042Design and development of medical technologies, namely, imaging apparatuses and equipment all for scientific and medical research; design and development of software in the framework of medical technology; design and development of medical imaging and diagnostic apparatus and developments of medical and scientific procedures and methods for measuring brain structure and function; provision of information in connection with medical and scientific research in the field of neuroscience, neurotechnology, and connectomics; computer programming in the medical field; medical research; biological and medical research services; scientific research in relation to medical technologies, medical apparatus, neuroscience, neurotechnology, cognitive science, healthcare, artificial intelligence and machine learning for the analysis of medical images and other measures of brain structure and function and connectomics; scientific research for medical purposes; scientific research services, namely, scientific research, analysis, and testing in the field of medical imaging and diagnostics and other methods for measuring brain structure and function; scientific and technological services, namely, scientific research, analysis, and testing in the field of medical imaging and diagnostics and other methods for measuring brain structure and function; design and writing of computer software, namely, computer program for medical applications; technical research in the field of neuroscience, cognitive science, machine learning, neurotechnologies and connectomics; design of computers for others; design and development of computer hardware and software for use in neurotechnologies and brain computer interfaces; software design relating to medical technologies, medical apparatus, medical imaging, diagnostic apparatus, neuroscience, neurotechnology, cognitive science, artificial intelligence and machine learning for the analysis of medical images and other measures of brain structure and function and connectomics; software development relating to medical technologies, medical apparatus, medical imaging, diagnostic apparatus, neuroscience, neurotechnology, cognitive science, machine learning and connectomics; research and development of new products in the fields of medical technologies, medical apparatus, medical imaging, diagnostic apparatus, neuroscience, neurotechnology, cognitive science, machine learning and connectomics for others; conducting scientific feasibility studies in the field of neurotechnologies and brain computer interfaces; software development and design; software installation of software relating to medical technologies, medical apparatus, medical imaging, diagnostic apparatus, neuroscience, neurotechnology, cognitive science, machine learning and connectomics; software maintenance of software relating to medical technologies, medical apparatus, medical imaging, diagnostic apparatus, neuroscience, neurotechnology, cognitive science, machine learning and connectomics; updating of software relating to medical technologies, medical apparatus, medical imaging, diagnostic apparatus, neuroscience, neurotechnology, cognitive science, machine learning and connectomics; rental of computer software relating to medical technologies, medical apparatus, medical imaging, diagnostic apparatus, neuroscience, neurotechnology, cognitive science, machine learning and connectomics; computer programming relating to medical technologies, medical apparatus, medical imaging, diagnostic apparatus, neuroscience, neurotechnology, cognitive science, machine learning and connectomics; computer system analysis relating to medical technologies, medical apparatus, medical imaging, diagnostic apparatus, neuroscience, neurotechnology, cognitive science, machine learning and connectomics; computer system design relating to medical technologies, medical apparatus, medical imaging, diagnostic apparatus, neuroscience, neurotechnology, cognitive science, machine learning and connectomics; services provided by consultants relating to computer hardware design and development of computer hardware relating to medical technologies, medical apparatus, medical imaging, diagnostic apparatus, neuroscience, neurotechnology, cognitive science, machine learning and connectomics; cloud computing, namely, cloud hosting provider services for brain imaging data and other measures of brain structure and function; styling being industrial design relating to medical technologies, medical apparatus, medical imaging, diagnostic apparatus, neuroscience, neurotechnology, cognitive science, machine learning and connectomics; software as a service (saas) services featuring software for neuroscience, neurotechnology, and connectomics research for use in the fields of medical and healthcare; software as a service (saas) services featuring software for medical imaging and diagnostics for use in the fields of medical and healthcare; software as a service (saas) services featuring software for diagnosis, treatment, treatment efficacy evaluation, and patient follow-up; software as a service (saas) services featuring software using artificial intelligence and machine learning algorithms to analyze medical images and other measures of brain structure and function; software as a service (saas) services featuring software for use in analyzing, accessing, monitoring, and sharing medical images and other measures of brain structure and functionACTIVEJul 15, 2026

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 18, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 18, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 27, 2026SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jul 27, 2026CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jul 19, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jul 17, 2026IUAFUSE AMENDMENT FILED—
Jul 17, 2026EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jun 12, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 11, 2026EX5GSOU EXTENSION 5 GRANTED—
Jun 10, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 20, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 19, 2026EXT5SOU EXTENSION 5 FILED—
Jul 18, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 17, 2025EX4GSOU EXTENSION 4 GRANTED—
Jul 17, 2025EXT4SOU EXTENSION 4 FILED—
Jul 17, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 3, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 18, 2025EX3GSOU EXTENSION 3 GRANTED—
Jan 17, 2025EXT3SOU EXTENSION 3 FILED—
Jan 17, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 16, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 16, 2024EX2GSOU EXTENSION 2 GRANTED—
Jul 16, 2024EXT2SOU EXTENSION 2 FILED—
Jul 16, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 20, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 18, 2024EX1GSOU EXTENSION 1 GRANTED—
Jan 18, 2024EXT1SOU EXTENSION 1 FILED—
Jan 18, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 18, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 23, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 23, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 3, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 14, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 14, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Apr 14, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 14, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 14, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 15, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 14, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 14, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 14, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 14, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 14, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 6, 2022DOCKASSIGNED TO EXAMINER—
Dec 1, 2021MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Nov 30, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 27, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance